Company

REYON Pharmaceutical Co. Ltd

Headquarters: Seoul, South Korea

Employees: 507

CEO: Ms. Soon-Ock Jung

KRX: 102460 +1.17%

Market Cap

₩302.81 Billion

KRW as of Jan. 1, 2024

US$233.9 Million

Market Cap History

REYON Pharmaceutical Co. Ltd market capitalization over time

Evolution of REYON Pharmaceutical Co. Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of REYON Pharmaceutical Co. Ltd

Detailed Description

REYON Pharmaceutical Co., Ltd. manufactures and sells finished medicines and APIs in South Korea and internationally. The company offers its products under the areas of adrenal corticosteroides; angiotensin II receptor antagonists; anticholinergics; antiemetic; antihypertensives; anti-inflammatory enzymes; antilipidemic, antirheumatic, and oral hypoglycemic agents; anti-peptic ulcer; antispasmodics; benign prostatic hypertrophy; cough and cold remedies; cardiac stimulant; genitourinary smooth muscle relaxants; hemostatics; immunosuppressants; rheumatoid arthritis; local anesthetics; migraine drugs; miscellaneous cardiovascular system drugs; neuromuscular disorder related drugs; nootropics and neurotonics; NSAIDs; respiratory stimulants; skeletal muscle relaxants; and vasodilators. REYON Pharmaceutical Co., Ltd. was founded in 1955 and is headquartered in Seoul, South Korea.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

REYON Pharmaceutical Co. Ltd has the following listings and related stock indices.


Stock: KRX: 102460 wb_incandescent

Details

Headquarters:

416 Yeongdong-daero

8th Floor Gangnarn-gu

Seoul, None

South Korea

Phone: 82 2 793 5557